Jon Duke

3.8k total citations · 1 hit paper
52 papers, 2.2k citations indexed

About

Jon Duke is a scholar working on Health Information Management, Toxicology and Molecular Biology. According to data from OpenAlex, Jon Duke has authored 52 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Health Information Management, 11 papers in Toxicology and 9 papers in Molecular Biology. Recurrent topics in Jon Duke's work include Electronic Health Records Systems (14 papers), Pharmacovigilance and Adverse Drug Reactions (11 papers) and Biomedical Text Mining and Ontologies (9 papers). Jon Duke is often cited by papers focused on Electronic Health Records Systems (14 papers), Pharmacovigilance and Adverse Drug Reactions (11 papers) and Biomedical Text Mining and Ontologies (9 papers). Jon Duke collaborates with scholars based in United States, Australia and South Korea. Jon Duke's co-authors include Martijn J. Schuemie, Patrick Ryan, Christian Reich, George Hripcsak, Marc A. Suchard, Nicole Pratt, Vojtech Huser, Rae Woong Park, Nigam H. Shah and G. Niklas Norén and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Jon Duke

50 papers receiving 2.1k citations

Hit Papers

Observational Health Data Sciences and Informatics (OHDSI... 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Duke United States 23 490 465 463 265 262 52 2.2k
Christian Reich United States 21 487 1.0× 575 1.2× 617 1.3× 303 1.1× 431 1.6× 57 3.0k
Rae Woong Park South Korea 28 626 1.3× 628 1.4× 763 1.6× 153 0.6× 377 1.4× 191 3.7k
David Madigan United States 24 249 0.5× 335 0.7× 690 1.5× 528 2.0× 142 0.5× 47 2.6k
Taxiarchis Botsis United States 20 387 0.8× 412 0.9× 569 1.2× 246 0.9× 83 0.3× 59 1.9k
Paea LePendu United States 21 156 0.3× 571 1.2× 504 1.1× 436 1.6× 181 0.7× 40 1.9k
Jianying Hu United States 25 490 1.0× 590 1.3× 1.0k 2.2× 70 0.3× 118 0.5× 77 2.6k
Peggy Peissig United States 28 531 1.1× 972 2.1× 844 1.8× 79 0.3× 198 0.8× 91 2.8k
Abraham G. Hartzema United States 37 216 0.4× 339 0.7× 242 0.5× 488 1.8× 331 1.3× 113 4.4k
Lemuel R. Waitman United States 27 628 1.3× 413 0.9× 420 0.9× 108 0.4× 282 1.1× 91 2.6k
Li Zhou United States 34 558 1.1× 541 1.2× 842 1.8× 290 1.1× 119 0.5× 172 3.4k

Countries citing papers authored by Jon Duke

Since Specialization
Citations

This map shows the geographic impact of Jon Duke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Duke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Duke more than expected).

Fields of papers citing papers by Jon Duke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Duke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Duke. The network helps show where Jon Duke may publish in the future.

Co-authorship network of co-authors of Jon Duke

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Duke. A scholar is included among the top collaborators of Jon Duke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Duke. Jon Duke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ruijun, Marc A. Suchard, Harlan M. Krumholz, et al.. (2021). Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. Hypertension. 78(3). 591–603. 104 indexed citations
2.
You, Seng Chan, Harlan M. Krumholz, Marc A. Suchard, et al.. (2021). Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients. Hypertension. 77(5). 1528–1538. 19 indexed citations
3.
Duke, Jon, et al.. (2021). A Modified Public Health Automated Case Event Reporting Platform for Enhancing Electronic Laboratory Reports With Clinical Data: Design and Implementation Study. Journal of Medical Internet Research. 23(8). e26388–e26388. 6 indexed citations
4.
Dixon, Brian E., et al.. (2019). Integration of FHIR to Facilitate Electronic Case Reporting: Results from a Pilot Study. Publisher. 1 indexed citations
5.
Dixon, Brian E., et al.. (2019). Integration of FHIR to Facilitate Electronic Case Reporting: Results from a Pilot Study. Studies in health technology and informatics. 264. 940–944. 7 indexed citations
6.
Abedtash, Hamed & Jon Duke. (2017). An Interactive User Interface for Drug Labeling to Improve Readability and Decision-Making.. PubMed. 2015. 278–86. 3 indexed citations
7.
Choi, Edward, Siddharth Biswal, Bradley Malin, et al.. (2017). Generating Multi-label Discrete Electronic Health Records using Generative Adversarial Networks.. arXiv (Cornell University). 24 indexed citations
8.
Choi, Edward, Siddharth Biswal, Bradley Malin, et al.. (2017). Generating Multi-label Discrete Patient Records using Generative Adversarial Networks. 286–305. 24 indexed citations
9.
Starr, R., et al.. (2017). OMOP on FHIR as an Enabler for Analytics-As-A-Service.. AMIA. 1 indexed citations
10.
Chattopadhyay, Debaleena, et al.. (2017). Design and Evaluation of Trust–Eliciting Cues in Drug–Drug Interaction Alerts. Interacting with Computers. 30(2). 85–98. 3 indexed citations
11.
Duke, Jon, et al.. (2016). NATURAL LANGUAGE PROCESSING TO IMPROVE IDENTIFICATION OF PERIPHERAL ARTERIAL DISEASE IN ELECTRONIC HEALTH DATA. Journal of the American College of Cardiology. 67(13). 2280–2280. 3 indexed citations
12.
Huser, Vojtech, Frank DeFalco, Martijn J. Schuemie, et al.. (2016). Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Datasets. SHILAP Revista de lepidopterología. 4(1). 24–24. 43 indexed citations
13.
Ryan, Patrick, Martijn J. Schuemie, Emily Welebob, et al.. (2013). Defining a Reference Set to Support Methodological Research in Drug Safety. Drug Safety. 36(S1). 33–47. 96 indexed citations
14.
Duke, Jon, Burke W. Mamlin, Douglas K. Martin, et al.. (2013). Regenstrief Institute's Medical Gopher: A next-generation homegrown electronic medical record system. International Journal of Medical Informatics. 83(3). 170–179. 25 indexed citations
15.
Duke, Jon, Burke W. Mamlin, & Douglas K. Martin. (2012). Regenstrief Institute's Next-Generation Clinical Decision Support System.. AMIA. 1 indexed citations
16.
Duke, Jon, Xue Li, & Paul Dexter. (2012). Adherence to drug--drug interaction alerts in high-risk patients: a trial of context-enhanced alerting. Journal of the American Medical Informatics Association. 20(3). 494–498. 48 indexed citations
17.
Zachariah, Mathew, Shobha Phansalkar, Hanna M. Seidling, et al.. (2011). Development and preliminary evidence for the validity of an instrument assessing implementation of human-factors principles in medication-related decision-support systems--I-MeDeSA. Journal of the American Medical Informatics Association. 18(Supplement 1). i62–i72. 40 indexed citations
18.
Duke, Jon. (2011). A Quantitative Analysis of Adverse Events and “Overwarning” in Drug Labeling. Archives of Internal Medicine. 171(10). 941–941. 36 indexed citations
19.
Duke, Jon, Xiaochun Li, & Shaun J. Grannis. (2009). Data visualization speeds review of potential adverse drug events in patients on multiple medications. Journal of Biomedical Informatics. 43(2). 326–331. 29 indexed citations
20.
Bain, Max, et al.. (1989). Free text retrieval systems: a review and evaluation. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026